INTRODUCTION
Although mammography remain s the most sen sitive method for detecting preclinical breast car cinoma, its limited specificity resu lts in need to biopsy many abnormalities to determine whether they are benign or malignant. I 2 Indi cations for breast sonography include the following: the in itial eva luation of palpable abnormalities in women under 30, initial identification and characterization of palpable and nonpalpable abnorm alities, guid ance of interventional procedures, and evaluatio n of problems associated with breast implants 34 Several recent studies suggest that sonography in combination with mammography can reduce the number of false-positive recommendations for bi opsy.S-B Mammography remains the standard for breast screen ing as most ductal carc in oma in situ is mi ssed sonographically9-1 I The growing use of ultrasonography has created the need for a standardized method for lesion characterization, descri ption, and reporting.1 2 The mammography lexicon developed by the ACR, the Breast Imaging Reporting and Data System (BI-RADSTM),13 provides sta ndardized assessment and assoc iated management recommendations for masses and calcifications. Based on success of BI-RADS with mammography , the development of a lexicon for breast ultrasound (BIRADS: Cltra sound) and breast magnetic resonance imaging 14 has been a high priority for the ACR. The lexicons are designed to use shared terminology whenever possible. When com pleted, the lexicons will aid refelTing physician s, radiologists , and patients in describing abnormalities and understanding their management implications. Furthermore, these lex icons will provide a basis for validation of out comes across multiple centers.
A breast ultrasound lexicon_ the Breast Imaging Reporting and Data System: l'Jtrasound is cur rently being developed by the ACR. The initial draft was prepared by the Breast Cltrasound Lex icon Subcommittee of an Expert Working Group to Plan and Develop Protocol s for Optimization and Clinical Te sting of Breast Ultrasound, supported by a contract from the Offlce of Women's Health, National Institutes of Health, and conducted by the Commission on Ultrasound of the ACR. Tech niq ues adapted from those used in the development of BI-RADS are being used in the formulation of the new ultrasound lexicon. The ACR lexicon is ex pected to be completed and released j n late 200 1 follo wing its validation. 
FEATURE ANALYSIS
Lesion features include primary fea tures such as shape (Fig 1) , orientation (Fig 2) , margins (Figs 3 through 5) , matri x echogenicity and homogeneity (Figs 6 and 7), and attenuation (Fig 8) , which should be described and applied in a consistent fashion. In additi on, secondary associated findings such as architectural distortion (Fig 9) , retraction or angulation of Cooper's ligaments (Fig 9B) , di lated ducts, calcificatio ns (Fig 10) and changes in the ski n, subcutaneous fat, and pectoral mu scle can be recorded as well . These fea tures of masses have been enumerated previously.5.7.15. 16 The utility of each category of features requires validati on along with that of individu al descriptors. For examp le, matrix homogeneity probably has less specificity and significance than description of mass marg in s. The most appropriate descriptor for each category of characteristics shou ld be applied whe n desc rib in g a lesion ( Table 1) . Wherever poss ible, fea ture descriptors similar to those used by BI-RADS fo r mammography have been imported. As with mam mography, use of the lexicon is predicated on Orientation . Mass orientation refers to the relation ship of the long axis of the mass to the skin . This may be parallel as is common with fibroadenomas (A) or not parallel , a common orientation for many cancers (B). Because round lesions do not have one axis that is longer than another, they should be classified as not parallel. Margins. The margin is the boundary between the lesion and its surroundings . Several characteristics of the lesion margin are important. The margin should be described as circumscribed (distinct and smooth) (A) or irregular (indis tinct, microlobulated, angUlar, or spiculated) (B). In A, the circumscribed margin of a fibroadenoma is shown. In B, an invasive cancer demonstrates an ill -defined or indistinct in terface with the surrounding tissues . As in mammography, ill-defined margins are associated with higher risk of malig nancy than circumscribed margins.
exce llent sonographic technique using a linear transd ucer whose center frequ ency is at least 7 MHz. Documentation should be performed in ac cord with the American Colle oe of Radioloay eo c
Standards.' Orthogonal v iews of the lesion should be obtain ed, and the orientati on of the transducer and location of the a bnormality should be de scribed using quadran t, clock-fac e location. andlor labeled diagram of the breast, ideall y including distance from the nipple. Several pre vious studies 5 .. 15 reach the conclu sion that multiple features must be analy zed to achie ve as great a specificity as possible in sono graphi c charac teri zati on . As an example, the diag nosis of a mass as a si mple cyst requires th at the shape be rou nd oval, or gently lobul ated , margin circumscribed, echogenicity (echo pattern) ane choic. and th at there be acoustic enhancement. Based on these combined features, the impress ion is that of a simpl e cyst (Fi gs 1. 5, and 6). The final assessme nt for the combination of mammographic and sonographic fi nding s using BI-RADS is cate gory 2, benign , with routine screening recom mended. The accuracy of so nographi c identifica ti on of cysts approaches 100%, provided stric t ad he rence to the classical sonograp hic charac teri s tics are observed . 17
Prac tical use of any lexicon req uires an under stand ing of the de fin iti ons of each term. An exam pJe is complicated vers us complex. The prese nce of homogeneous low-level internal echoes thro ug holl t a cystic lesion that has all the o ther features of a sim ple cyst as above results in its designati o n as "complicated. "18 M any of these masses appear solid , albeit be nig n, a nd may be repo rted as "co m plicated cyst or probabl y ben ig n solid lesion." Often, such lesio ns are incidentall y found d uring ul traso und examin ation peIiorm ed for oth er rea sons. Recent studies cumul ative ly evalu ating 567 incide ntal compli cated cys ts identifi ed onl y o ne 3-mm in situ ma lig na ncy (positive predi ctive value [PPY] 0.2%).1 9-21 Based on these data, short-term follo w-up appears appropriate (BI-RADS category 3, probabJ y ben ign), although further validation is encouraged. Interval enl argement (mammographi call y or sonograph ical ly), or th e prese nce of any suspicio us features, sho uld prompt aspi ration and possible core biopsy if it proves solid 22 Su spicious features include an intracy stic m ass/ mural nod ule, thick septations , or a thi ck or irreg ul ar wall. When such fea tures are present, the m ass sho uld be desc ribed as a "complex" cystic m ass (Figs 7B and C). T hese lesio ns gene rall y requ ire aspiration or biopsy (BI-RADS category 4, susp i cious) .
When a so lid lesion is presen t, careful analysis of conto ur. margins, matri x, and atte nuati o n may a ll ow classification of some nodul es as BI-RA DS category 3, prob ab ly benign, and provide the op ti on of short interva l follow-up at 6 months, 12 mo nths, a nd 24 mon th s, rath er than biopsy .5-7 As in ma mmography, fo r a lesio n to be assessed as "probably beni gn," it should have <2% risk of malignancy 23.24 As mentioned, preliminary data suggest cysts with internal ec hoes can be so clas sified as can clusters of tin y cystic foci wi th thin intervening se ptati o ns compatible with apocrine me taplas ia. 25 Stavros et a]5 proposed three categories of solid lesions that could be class ified as BI-RADS cate gory 3, probably benign, in the absence of any suspicious features: (I) masses with intense and uniform hyperechogenicity re lative to fat ; (2) masses with an ellipsoid shape and thin echogenic capsule; and (3) masses with two or three gentle lobulation s and a thin echogenic capsu le. Individ ually each of these characteristics had a negative predictive va lue for malignancy of 98.8 % to 1009'0.5 Although accepted by some, it is important to note that these results have not been validated across multiple centers. Indeed , one recent study26 suggests that not all readers achieve sufficiently high specificity to fo ll ow so lid lesion s. [n the draft BI-RADS:Ultrasound lexicon, the concept of a thin echogenic caps ule or " pseudocaps ule-' has been replaced by that of a thin, smooth margin , analo gous to a "circumscribed" mass mammographi cally. Although palpable, solid lesions are gener ally recommended for biopsy ,2:l.24 it is not yet clear whether any size criterion or palpability of the lesion influences the absolute risk of malignancy.
For solid masses, irregularity of shape and margin s dominate other features suggesting mali g nancy , with a PPY of ma lignancy of 86% to 93 %5 .7: s uch lesions are appropriately classified as BI-RADS category 4 or 5 with biopsy recom mended . Other feature s have lower specificity.
Orientation of the long axis of the mass nonparal lel to the skin, synonymously termed "taller than wide,"5 has been associated with a 62% to 81 Ok. likelihood of malignancy5.7 and is more common ly seen in cancers < 1 cm in size.' Ylost fibroadeno mas as well as many cancers are oriented with their long axes parallel to the skin ("wider than tall") J I Echotexture!echo pattern appears to be less helpful in differentiating benign fro m malign an t sol id MENDELSON. BERG . AND MERRITI masses " I as most masses will be hypoechoic to pare nchyma. Acoustic attenuation (shadowing) is suspicious for malignancy, but as many as 2 1 % of benign les ions will show shadowing7 Similarly, acoustic enhancement, while common in benign lesions. may be present in up to 42% of cancers. s Several typically benign lesion s are included as special cases (Fig 11) . This includes lymph nodes with a thin circumscribed capsule and centra l echogenic hi lum. Foreign bodies are spec ial cases and include siliconomas and free extracapsu lar silicone (Fig 11) ,27 Description of vascu larity of the lesion is not a required standard (Fig 12) as no reliable distinction has yet been made between 30 benign and malignant lesion s on this basis 2 8 Vasc ularity is described as the same, increased_ or decreased, relative to surrounding parenchyma. Table I is a worki ng draft of a breast ultrasound lexicon including feature categories and descrip tors. Although different in format, this draft was based largely on the version developed by the Lexicon Committee of the Expert Working Group. It is important to note that these recommendations awa it va lidation and are subject to modification before release of the final draft of the ACR BIRADS:l'ltrasound. Descriptors are illustrated in Figures 1 through 12 . The illu strations show only a ._-~ sing le view of each lesion. In prac ti ce, descri pto rs sho uld be based o n multiple views of masses obtained in orthogonal imaging pla nes, in accord with the ACR Standard for the Ultraso und Exa m in ation of the Breast. 3 Primary descriptors of masses (shape, ori entation, m argin, and echo pat tem ) are gene rall y listed in order of increasin g risk of maligna ncy, to p to bo tto m, altho ug h further validation of the risk of malignancy is needed. Sec ondary features, associated fi ndings, or effects on sUlTounding tiss ue are not listed in any particular order, as fLll1her assessment of the risk of mali gnancy for each feature is needed. In refen'ing to Tabk 1, it is important to re-emphasize th at greatest specific ity is achieved by the evaluation of multiple features of the mass rather th an any single attlibute.
Ce rtain prob le m s of descrip tion , nomencla ture, a nd ca tegori za tion have no t been reso lved. For exa mple . ove rl a p of s hape and m a rgin ca te go ries (e g, irreg ular) h as bee n discu sse d in the development of bo th mammography and ultra soun d lex icon s. Cse of the te rm " tu bular" may be a ppro pri a te as a s ha pe (Fi g 13) o r special case (eg. dil a ted du c t). The beni gn les io n, apocrine metap!asia ,l' with its charac terist ic m ic rolobu la ted margin bu t othe rwise iden ti fi ably beni g n m icrocys tic co m ponents (Fi g 14), might be a spec ia l case , be tte r includ ed a nd desc ri bed for its uni q ue ness th a n analyzed by indi vi dual desc ri p to rs such as irregu lar, m icro lobu lated , a nd com plex that woul d otherwise prompt ti ssue di ag no SI S .
Another dil e m ma is classifica tion of lesion s by Requires tissue sampling malignancy their echogenicity, that is_ defined relative to fat or fibroglandu/ar tissue. Some masses, notably fibro adenomas , are similar to fat lobules in shape and echogenicity. Should they be described as "hypo echoic," using fibroglandular tissue as the basis for comparison, just as fat lobules are hypoechoic to fibroglandular tissue , or should they be termed " isoechoic" to fat') Further in need of validation are the categories of thickness of circumscribed mar gins and the characterization of solid masses by their matrix homogeneity. \1any fibroadenomas are heterogeneous and some carcinomas are homo geneous. What is the predictive value of these features , alone or in combination with other fea tures?
FINAL ASSESSMENT
As with mammography , a Br-RADS final as sessment and recommendation should be specified (Table 2) . When breast sonography is pelformed as an adjunct to mammography, one final as sessment and management recommendation should be spec ified , which reflects combined mammographic and sonographic finding s. Final assessment and man-MENDELSON, BERG, AND MERRITI agement should be predicated on the basis of the most suspicious feature(s) present.
SUMMARY
The approach outlined above for describing and reporting sonographic feature s of breast masses represents only the initial step in the development of a comprehensive system to enhance the accurate identification, reporting, and analysis of sono graphic abnormalities of the breast. Future revi sions, with validation of interobserver consistency in application of these descriptors across multiple centers, with feedback from potential users in the breast imaging community, will undoubtedly ex pand the utility of this eff0l1.
